The landscape of drug discovery in atherosclerosis and dyslipidaemia revisited: an update of patenting activity

By Suckling Keith  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 3, 2012-03 ,pp. : 199-204

Informa Healthcare

Access to resources Recommend Favorite

What is the future for drug development in atherosclerosis and dyslipidaemia?

By Suckling Keith  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 1, 2009-01 ,pp. : 1-3

Informa Healthcare

Access to resources Recommend Favorite

Patenting transcription factors for drug discovery and therapeutics

By Manning A.M.   Gonzales R.   Bennett B.L.  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 3, 1997-03 ,pp. : 225-231

Informa Healthcare

Access to resources Recommend Favorite

Inflammation in Atherosclerosis: New Opportunities for Drug Discovery

By  

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 1, 2005-01 ,pp. : 33-40

Bentham Science Publishers

Access to resources Recommend Favorite

Modeling of activity landscapes for drug discovery

By Bajorath Jürgen  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 6, 2012-06 ,pp. : 463-473

Informa Healthcare

Access to resources Recommend Favorite